These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism. Fruchart JC; Duriez P Drugs Today (Barc); 2006 Jan; 42(1):39-64. PubMed ID: 16511610 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of fibrates in postprandial lipemia. Kolovou GD; Kostakou PM; Anagnostopoulou KK; Cokkinos DV Am J Cardiovasc Drugs; 2008; 8(4):243-55. PubMed ID: 18690758 [TBL] [Abstract][Full Text] [Related]
9. Field of confusion: future prospects for fibrate therapy in cardiovascular disease. Rosenson RS Curr Atheroscler Rep; 2006 May; 8(3):219-22. PubMed ID: 16640958 [No Abstract] [Full Text] [Related]
10. [Nicotinic acid in lipid metabolism disorders]. Ahmed K; Offermanns S Pharm Unserer Zeit; 2007; 36(2):120-5. PubMed ID: 17424997 [No Abstract] [Full Text] [Related]
11. Fibrate therapy in patients with metabolic syndrome and diabetes mellitus. Dayspring T; Pokrywka G Curr Atheroscler Rep; 2006 Sep; 8(5):356-64. PubMed ID: 16901405 [TBL] [Abstract][Full Text] [Related]
13. [Fibrate and its perspective as a drug for metabolic syndrome]. Tada N Nihon Rinsho; 2006 Dec; 64 Suppl 9():622-6. PubMed ID: 17458293 [No Abstract] [Full Text] [Related]
14. [Treatment of familial combined hyperlipidemia]. Bruckert E Ann Endocrinol (Paris); 1997; 58(4):297-301. PubMed ID: 9436478 [No Abstract] [Full Text] [Related]
16. Potential of fibrates in the treatment of fatty acid oxidation disorders: revival of classical drugs? Djouadi F; Aubey F; Schlemmer D; Gobin S; Laforet P; Wanders RJ; Strauss AW; Bonnefont JP; Bastin J J Inherit Metab Dis; 2006; 29(2-3):341-2. PubMed ID: 16763897 [TBL] [Abstract][Full Text] [Related]
17. [The action of a fibric acid derivative on lipid metabolism]. Filip M; Păduraru I; Nechifor M; Dănilă GH; Popovici I; Filip FM; Poşircă F Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):573-6. PubMed ID: 2636755 [TBL] [Abstract][Full Text] [Related]
18. Fibrates and microvascular complications in diabetes--insight from the FIELD study. Ansquer JC; Foucher C; Aubonnet P; Le Malicot K Curr Pharm Des; 2009; 15(5):537-52. PubMed ID: 19199980 [TBL] [Abstract][Full Text] [Related]
19. Nuclear peroxisome proliferator-activated receptors and thiazolidinediones. Grinberg A; Park KW Int Anesthesiol Clin; 2005; 43(2):1-21. PubMed ID: 15795559 [No Abstract] [Full Text] [Related]
20. Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates. Shiri-Sverdlov R; Wouters K; van Gorp PJ; Gijbels MJ; Noel B; Buffat L; Staels B; Maeda N; van Bilsen M; Hofker MH J Hepatol; 2006 Apr; 44(4):732-41. PubMed ID: 16466828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]